BARD ASSOCIATES INC
$398M in tracked AUM across 293 positions as of Q1 2026.
Bard Associates' $398M Q1 2026 filing is a fixed-income-and-energy-infrastructure portfolio — the top five positions are Janus Detroit (JAAA, $25.3M, 6.3%), iShares Preferred (PFF, $21.0M, 5.3%), Flaherty & Crumrine Preferred (XFFCX, $18.8M, 4.7%), Schwab Short-Term Treasury (SCHO, $12.3M, 3.1%), and Vanguard Real Estate (VNQ, $12.3M, 3.1%) — with Coherent Corp (COHR, $12.8M, 3.2%) the only single-name equity in the top ten and a healthcare name at that. The Q1 changes reveal a defensive rotation within the fixed-income core: JAAA was increased by $8.7M (+52% shares), SCHO by $5.6M (+83%), and VNQ by $50K — all short-duration or income-oriented strategies — while the manager cut XFFCX by $1.3M, PFF by $0.8M, and REZ (iShares Real Estate) by $0.2M. The energy-infrastructure sleeve (TYG, KYN, NEE, AROC, OR, USDmidstream names) was held relatively flat with only minor adjustments, suggesting the manager is satisfied with the existing duration and yield profile. The sharpest single move was a 30% reduction in Coherent Corp (-$1.5M), the portfolio's largest healthcare position, which the manager trimmed despite the stock appreciating — a signal that the healthcare allocation is being compressed in favor of the fixed-income core. Four new micro-cap positions opened in Q1 — Viemed Healthcare ($3.1M), Buda Juice ($3.1M), Intest ($2.9M), and Intellinetics ($2.5M) — all sub-$3M healthcare and technology names that read like venture-style satellite bets rather than core holdings. At 293 holdings with a whaleScore of 50.75, this is a yield-focused institutional portfolio where the meaningful signal is the deliberate shift toward shorter-duration fixed income and away from longer-duration preferred and real-estate credit.
Quarter at a glance — Q1 2026
Position-change comparison pending.
Top 10 holdings
By portfolio weight as of Q1 2026.